ADMA Adma Biologics Inc

ADMA Biologics Inc is a biopharmaceutical company. The Company develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases.

As of 11/26/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/17/2013
Outstanding shares:  195,813,817
Average volume:  2,831,737
Market cap:   $293,720,726
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    000899104
ISIN:        US0008991046
Valuation   (See tab for details)
PE ratio:   -3.82
PB ratio:   1.95
PS ratio:   4.29
Return on equity:   -72.39%
Net income %:   -108.60%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy